JBIO (Jade Biosciences) Construction In Progress: $0.00 Mil (As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $21.81
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Construction In Progress?

Jade Biosciences JBIO -1.85% 12 Construction In Progress is $0.00 Mil as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Jade Biosciences Construction In Progress Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Construction In Progress Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Construction In Progress
0.00 0.00

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
JBIO
12GF Score
Jade Biosciences Inc JBIO
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.00 Mil mean?
Jade Biosciences (JBIO) has a Construction In Progress of $0.00 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Jade Biosciences and its competitors.
Is Jade Biosciences' Construction In Progress too high?
Jade Biosciences' current Construction In Progress is $0.00 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Construction In Progress compare to AVLN and ARDX?
Jade Biosciences' Construction In Progress of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Construction In Progress is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Construction In Progress of $0.00 Mil. The current Construction In Progress is $0.00 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Construction In Progress is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.81
Price